Nutex Health (NASDAQ:NUTX) Stock Price Target Raised at B. Riley Financial

Nutex Health (NASDAQ:NUTX) had its price target hoisted by equities research analysts at B. Riley Financial from $325.00 to $357.00 in a note issued to investors on Monday, Benzinga reports. The firm currently has a “buy” rating on the stock. B. Riley Financial‘s target price would indicate a potential upside of 91.09% from the company’s previous close.

A number of other equities analysts have also recently commented on the company. Zacks Research cut Nutex Health from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 6th. Lake Street Capital restated a “buy” rating and set a $310.00 price target (up from $235.00) on shares of Nutex Health in a report on Tuesday, August 11th. Wall Street Zen lowered Nutex Health from a “buy” rating to a “hold” rating in a report on Saturday, October 31st. Weiss Ratings upgraded Nutex Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday, October 6th. Finally, LADENBURG THALM/SH SH began coverage on Nutex Health in a research report on Monday, October 26th. They issued a “buy” rating and a $336.00 price target for the company. Four investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $334.33.

Nutex Health Trading Up 3.5%

NUTX traded up $6.26 on Monday, hitting $186.82. The company had a trading volume of 17,063 shares, compared to its average volume of 166,292. The business’s fifty day simple moving average is $203.11 and its 200 day simple moving average is $151.38. The company has a quick ratio of 4.96, a current ratio of 5.00 and a debt-to-equity ratio of 0.59. Nutex Health has a 12-month low of $83.99 and a 12-month high of $226.16. The company has a market cap of $1.28 billion, a PE ratio of 7.95 and a beta of 0.66.

Nutex Health (NASDAQ:NUTX) last issued its quarterly earnings data on Thursday, November 5th. The company reported $5.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.54 by $0.17. Nutex Health had a return on equity of 35.99% and a net margin of 20.68%. The business had revenue of $217.61 million for the quarter, compared to the consensus estimate of $214.82 million. Equities research analysts expect that Nutex Health will post 26.65 EPS for the current year.

Insider Buying and Selling

In related news, Director Scott Saunders sold 203 shares of the stock in a transaction dated Friday, September 18th. The shares were sold at an average price of $214.25, for a total value of $43,492.75. Following the sale, the director directly owned 400 shares of the company’s stock, valued at $85,700. This represents a 33.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 44.68% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of NUTX. Kilter Group LLC bought a new position in shares of Nutex Health during the second quarter valued at approximately $27,000. Allworth Financial LP purchased a new stake in shares of Nutex Health in the second quarter worth approximately $35,000. GK Wealth Management LLC purchased a new stake in shares of Nutex Health in the third quarter worth approximately $73,000. EverSource Wealth Advisors LLC purchased a new stake in shares of Nutex Health in the first quarter worth approximately $83,000. Finally, State of Alaska Department of Revenue lifted its stake in shares of Nutex Health by 243.6% during the 3rd quarter. State of Alaska Department of Revenue now owns 1,000 shares of the company’s stock worth $211,000 after acquiring an additional 709 shares during the last quarter. Hedge funds and other institutional investors own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, medical facilities and physician practices in the United States. The company focuses on providing convenient, community-based care through its micro-hospitals and other healthcare locations.

Its hospital operations generally include emergency services, inpatient care, diagnostic testing and outpatient treatment. Nutex also operates physician networks and supports primary care and specialty providers.